Latest AI and machine learning research in chemotherapy for healthcare professionals.
OBJECTIVES: Our objective is to develop a deep learning-based artificial intelligence (AI) model capable of analyzing digital mammography (DM) images to predict axillary lymph node (ALN) status subsequent to neoadjuvant therapy (NAT) in breast cancer patients. MATERIALS AND METHODS: We developed and validated an AI model for predicting post-NAT ALN status using images and clinical data of 956 inva...
The treatment paradigm for locally advanced rectal cancer is undergoing a fundamental transformation from the traditional fixed triad of "radiotherapy...
Pancreatic adenosquamous carcinoma (PASC) is a rare exocrine malignancy of the pancreas with an increasing incidence, histologically defined by the co...
Single-atom platinum on graphitic materials can enhance catalysis of the oxygen reduction reaction (ORR). The local atomic structure shapes catalytic ...
OBJECTIVES: Achieving a pathological complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal c...
PURPOSE OF REVIEW: Pleural mesothelioma remains a universally lethal cancer with a rising global burden. This underscores the need for pulmonologists ...
OBJECTIVE: To compare the analgesic efficacy and safety of liposomal bupivacaine (LB) versus ropivacaine for surgical incision local anesthesia after ...
BACKGROUND: Lack of readily available recurrence data has limited the use of electronic health records (EHR) for risk assessment of cancer recurrence ...
BACKGROUND: Prognostic information is essential for decision-making in breast cancer management. In recent years, trials and clinical practice have em...
AIMS: To identify body temperature dynamic patterns and develop a machine learning model for the early detection of nosocomial infections. DESIGN: A r...
Precise survival risk stratification for bladder urothelial carcinoma (BUC) remains a clinical challenge. We developed and validated a multimodal AI a...
The therapeutic gain ratio (TGR) of radiotherapy for hepatocellular carcinoma (HCC) remains limited by two major barriers: insufficient precision in a...
Chemotherapy-induced madarosis significantly impacts patient quality of life, yet current assessment methods rely heavily on subjective grading, limit...
Neoadjuvant therapy (NAT) has emerged as a standard treatment strategy for locally advanced breast cancer (BC), yet robust biomarkers for response pre...
Chemotherapy response in colorectal cancer (CRC) exhibits significant heterogeneity, with current clinical predictors failing to capture complex genom...
INTRODUCTION: High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of ovarian cancer. Although tumour stage and complete cytor...
Thymic epithelial tumors (TETs), comprising thymomas, thymic carcinomas, and thymic neuroendocrine neoplasms, are rare prevascular (anterior) mediasti...
BACKGROUND: Response evaluation of pancreatic ductal adenocarcinoma (PDAC) with routine contrast-enhanced CT (CECT) using RECIST is currently inadequa...